CORRECTION article
Front. Oncol.
Sec. Hematologic Malignancies
Case Report: renal allograft infiltration by chronic lymphocytic leukemia successfully treated with zanubrutinib
Brian Abboud 1
Nehemias Guevara Rodriguez 2
Arslan Barbar 2
Noemy Coreas 3
Katherine Robbins 4
Ranju Kunwor 2
1. Department of Internal Medicine, SSM Health Saint Louis University Hospital, St. Louis, United States
2. Division of Hematology, Oncology and Bone Marrow Transplant, Department of Internal Medicine, SSM Health Saint Louis University Hospital, St. Louis, United States
3. Department of Gynecologic Oncology,Salvadoran Social Security Institute (ISSS), University of El Salvador (UES), San Salvador, El Salvador
4. Department of Pathology, SSM Health Saint Louis University Hospital, St. Louis, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract
A correction refers to a change to their article that the author wishes to publish after publication. The publication of this article is subject to Frontiers' editorial approval. • Please read through all the templates before choosing • Pick the most relevant text template(s) from the following page and delete all others.• Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • Submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used.The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated.
Summary
Keywords
Bruton tyrosine kinase (BTK) inhibitor, CLL (chronic lymphocytic leukemia), Hematolgy, Immunosuppression, Malignant Hematologic Disease, renal transplant, zanubrutinib, zanubrutinib Acute Kidney Injury as initial manifestation of chronic lymphocytic leukemia/small lymphocytic lymphoma
Received
12 February 2026
Accepted
17 February 2026
Copyright
© 2026 Abboud, Guevara Rodriguez, Barbar, Coreas, Robbins and Kunwor. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Brian Abboud
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.